Efficacy and safety of tyrosine kinase inhibitors plus PD-1 inhibitor in patients with transarterial chemoembolization- refractory hepatocellular carcinoma: a two-center retrospective study

Gao, Y; Lu, HH; Xiong, ZF

Xiong, ZF (通讯作者)，Huazhong Univ Sci & Technol, Liyuan Hosp, Tongji Med Coll, Dept Gastroenterol, Wuhan, Hubei, Peoples R China.;Lu, HH (通讯作者)，Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Radiol, Wuhan, Hubei, Peoples R China.

FRONTIERS IN ONCOLOGY, 2023; 13 ():

Abstract

ObjectTo investigate the efficacy and safety of tyrosine kinase inhibitors (TKIs: sorafenib and lenvatinib) plus PD-1 inhibitor (camrelizumab) versus ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索